Capstone Investment Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,978
Closed -$366K 1844
2026
Q1
$366K Buy
+10,978
New +$460K ﹤0.01% 1286
2024
Q2
Sell
-12,620
Closed -$369K 2353
2024
Q1
$369K Buy
+12,620
New +$383K ﹤0.01% 1723
2023
Q3
Sell
-3,475
Closed -$256K 2236
2023
Q2
$256K Buy
+3,475
New +$234K ﹤0.01% 1460
2017
Q4
Sell
-3,920
Closed -$200K 609
2017
Q3
$200K Buy
+3,920
New +$188K 0.01% 479
2016
Q4
Sell
-9,265
Closed -$354K 1058
2016
Q3
$354K Buy
+9,265
New +$345K 0.01% 574

Other funds holding OMCL

Capstone Investment Advisors's OMCL Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 10,978 shares — an estimated $366K sold.

Capstone Investment Advisors first reported a position in OMCL in Q3 2016 and held it in 5 quarters. The position peaked at $369K in Q1 2024. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 10,978 Omnicell shares in Q2 2026, an estimated $366K.
  • Capstone Investment Advisors first reported a position in Omnicell in Q3 2016 and held it in 5 quarters.
  • Capstone Investment Advisors's Omnicell position peaked at $369K in Q1 2024.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.